Vitamin D has been recognized for several decades as an important player in bone metabolism. Beyond these classic effects on mineral metabolism, it has numerous extra-osseous effects, including effects on the cardiovascular system. Indeed, several clinical studies suggest a link between vitamin D deficiency and cardiovascular mortality. The general objective is to evaluate the relationship between vitamin D levels and lipid parameters in patients at Fann University Hospital. Included in this study were 214 patients who came to the laboratory and whose vitamin D dosage was requested between December 2023 and April 2024. Lipid profile parameter dosages were performed with the Architect Ci4100 and vitamin D with Iflash 3000. Correlations between vitamin D levels and blood lipids were assessed by descriptive statistical analysis and Spearman's correlation test. The mean age of our population was 60±17 years and the sex ratio was 0.51. The distribution of patients according to the lipid profile showed that 72.42% of the subjects had a lipid abnormality with a predominance of hypo HDL-cholesterolemia (39.71%). Our study showed a positive and significant correlation between low vitamin D levels and low HDL-cholesterol levels. In contrast, no strong link was found with the levels of total cholesterol, triglycerides and LDL-cholesterol. These results highlight the importance of monitoring vitamin D levels in patients with dyslipidemia, and pave the way for future research on the potential role of vitamin D in cardiovascular risk management.
Published in | Advances in Biochemistry (Volume 13, Issue 1) |
DOI | 10.11648/j.ab.20251301.11 |
Page(s) | 1-6 |
Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
Copyright |
Copyright © The Author(s), 2025. Published by Science Publishing Group |
Vitamin D, Dyslipidemia, Cardiovascular Risk
Dyslipidemias | Threshold values |
---|---|
Hypercholesterolemia | Total cholesterol >2 g/l |
Hypertriglyceridemia | Triglycerides >1.5 g/l |
Mixed Hyperlipidemia | Total cholesterol >2 g/l Triglycerides >1.5 g/l |
Hypo HDL-Cholesterolemia | HDL cholesterol <0.40 g/l (Men) HDL cholesterol <0.50 g/l (Women) |
Hyper LDL-Cholesterolemia | LDL cholesterol >1.3 g/l |
Included | 214 |
Average Age (years) | 60.40 ±17 |
Sex Ratio | 0.51 |
Minimum Vit D (ng/ml) | 1.98 |
Maximum Vit D (ng/ml) | 82.11 |
Mean Vit D (ng/ml) | 22.46±13 |
Median Vit D (ng/ml) | 18.82 |
Vit D Deficiency (<10 ng/ml) | 14.01% |
Vit D Insufficiency (10-30 ng/ml) | 64.48% |
Age groups (years) | Vitamin D (ng/ml) |
---|---|
[5-25[ | 22.20±13.3 |
[25-45[ | 22.68±13.7 |
[45-65[ | 22.5±13.8 |
[65-85[ | 22.4±13.7 |
[85-105[ | 21.7±13 |
Age groups (years) | 10<Vitamine D <30 | Vitamine D<10 |
---|---|---|
[5-25[ | 50% | 50% |
[25-45[ | 67.56% | 5.40% |
[45-65[ | 65.78% | 10.52% |
[65-85[ | 58.82% | 20% |
[85-105[ | 88% | - |
Dyslipidemias | Frequencies | Average Vitamin D |
---|---|---|
Presence | 72.42% | 22.46 ng/ml |
Absence | 27.57% | 22.51 ng/ml |
p value | <0.05* | 0.076 |
Parameters | Vitamine D | |
---|---|---|
Rho | p value | |
Triglycerides | -0.05 | 0.451 |
Total Cholesterol | 0.001 | 0.489 |
LDL Cholesterol | 0.01 | 0.487 |
HDL Cholesterol | 0.11 | 0.0487* |
ATP III | Adult Treatment Program III |
NCEP | National Cholesterol Education Program |
[1] | Mann D, Zipes D, Libby P, Bonow R. Braunwald’s Heart Disease: A Textbook of Cardiovascular Medicine. Single numero 10th edition. Boston: Sauders; 20142-040. |
[2] |
OMS, Maladies cardiovasculaires. Aide-memoire. Janvier 2015.
http://www.who.int/mediacentre/factsheets/fs317/fr/ (consultele12/03/2025). |
[3] | Lang PO. Supplémentation en vitamine D: pourquoi? Comment? Qui? Et avec quoi?. Neurologie - Psychiatrie – Gériatrie. 2013; 13(74): 63 70. |
[4] | Courbebaisse M, Cormier C. Vitamine D et santé cardiovasculaire. Cahiers de Nutrition et de Diététique. 2014; 49(6): 267-272 |
[5] | AlQuaiz, AM, Kazi, A., Youssef, RM et al. Association entre la vitamine 25(OH) D standardisée et la dyslipidémie: une étude communautaire à Riyad, en Arabie saoudite. Health Prev Med. 2020; 25(4). |
[6] | Gouni-Berthold I, Berthold HK. Vitamin D and Vascular Disease. Curr Vasc Pharmacol. 2021; 19(3): 250-268. |
[7] | Jorde R, Figenschau Y, Moira Hutchinson M, Emaus N, Grimnes G. Des concentrations sériques élevées de 25-hydroxyvitamine D sont associées à un profil lipidique sérique favorable. Eur J Clin Nutr. 2010; 64: 1457–1464. |
[8] | Lipsy RJ. The National Cholesterol Education Program Adult Treatment Panel III guidelines. J Manag Care Pharm. 2003 Jan-Feb; 9(1 Suppl): 2-5. |
[9] | Landrier JF. Vitamine D: sources, métabolisme et mécanismes d’action. Oilseeds and fats, Crops and Lipids. 2014; 21(3): 302. |
[10] | Bochud, M., Guessous, I. Vitamine D et maladie cardiovasculaire: aspects épidémiologiques, Rev Med Suisse. 2012; 8(360): 059–2065. |
[11] | Huang F, Liu Q, Zhang Q, Wan Z, Hu L, Xu R, Cheng A, Lv Y, Wang L. Sex-Specific Association between Serum Vitamin D Status and Lipid Profiles: A Cross-Sectional Study of a Middle-Aged and Elderly Chinese Population. J Nutr Sci Vitaminol (Tokyo). 2020; 66(2): 105-113. |
[12] | Daoudi N, Karmali R, Fuss M. Evaluation de la carence en vitamine D chez des patients hospitalisés a Bruxelles [Evaluation of vitamin D deficiency in hospitalized patients in Brussels]. Rev Med Brux. 2009; 30(1): 5-10. French. |
[13] |
Chauveau P, Aparicio M. Ethnicité et vitamine D [Ethnicity and vitamin D]. Nephrol Ther. 2013; 9(6): 398-402. French.
https://doi.org/10.1016/j.nephro.2013.03.012 Epub 2013 May 10. |
[14] | Christakos S, Dhawan P, Verstuyf A, Verlinden L, Carmeliet G. Vitamin D: Metabolism, Molecular Mechanism of Action, and Pleiotropic Effects. Physiol Rev. 2016; 96(1): 365‑408. |
[15] | Djerdap L, Ramdane S, Oussadou L. Épidémiologie de l’hypovitaminose D chez une population jeune adulte en bonne santé apparente en Algérie. Revue Médicale de Bruxelles. 2022; 43. |
[16] | Sharba ZF, Shareef RH, Abd BA, Hameed EN. Association between Dyslipidemia and Vitamin D Deficiency: a Cross-Sectional Study. Folia Med (Plovdiv). 2021; 63(6): 965-9. |
[17] | Rajakumar K, Moore CG, Khalid AT, Vallejo AN, Virji MA, Holick MF, et al. Effect of vitamin D3 supplementation on vascular and metabolic health of vitamin D-deficient overweight and obese children: a randomized clinical trial. Am J Clin Nutr. 2020; 111(4): 757-68. |
[18] | Surdu AM, Pînzariu O, Ciobanu DM, Negru AG, Căinap SS, Lazea C, et al. Vitamin D and Its Role in the Lipid Metabolism and the Development of Atherosclerosis. Biomedicines. 2021; 9(2): 172. |
[19] | Jiang X, Peng M, Chen S, Wu S, Zhang W. Vitamin D deficiency is associated with dyslipidemia: a cross-sectional study in 3788 subjects. Current Medical Research and Opinion. 2019; 35(6): 1059-63. |
[20] | Ponda MP, Huang X, Odeh MA, Breslow JL, Kaufman HW. Vitamin D May Not Improve Lipid Levels. Circulation. 2012; 126(3): 270-7. |
[21] | Kim MR, Jeong SJ. Relationship between Vitamin D Level and Lipid Profile in Non-Obese Children. Metabolites. 2019; 9(7): 125. |
[22] | Lacour B, Basile C, Drüeke T, Funck-Brentano JL. Parathyroid function and lipid metabolism in the rat. Miner Electrolyte Metab. 1982; 7(3): 157-65. |
APA Style
Matar, K. P., Mareme, T. N., Kesso, B. N. O., Moustapha, D., Godwin, N. J. C., et al. (2025). Correlation Between Vitamin D Levels and Dyslipidemia in Patients at Fann University Hospital. Advances in Biochemistry, 13(1), 1-6. https://doi.org/10.11648/j.ab.20251301.11
ACS Style
Matar, K. P.; Mareme, T. N.; Kesso, B. N. O.; Moustapha, D.; Godwin, N. J. C., et al. Correlation Between Vitamin D Levels and Dyslipidemia in Patients at Fann University Hospital. Adv. Biochem. 2025, 13(1), 1-6. doi: 10.11648/j.ab.20251301.11
@article{10.11648/j.ab.20251301.11, author = {Kandji Pape Matar and Thioune Ndeye Mareme and Barry Néné Oumou Kesso and Djite Moustapha and Nayo Jean Cédric Godwin and Ndiaye Siny and Coly Najah Fatou and Ndour El Malick and Gueye-Tall Fatou and Gueye Papa Madieye}, title = {Correlation Between Vitamin D Levels and Dyslipidemia in Patients at Fann University Hospital }, journal = {Advances in Biochemistry}, volume = {13}, number = {1}, pages = {1-6}, doi = {10.11648/j.ab.20251301.11}, url = {https://doi.org/10.11648/j.ab.20251301.11}, eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ab.20251301.11}, abstract = {Vitamin D has been recognized for several decades as an important player in bone metabolism. Beyond these classic effects on mineral metabolism, it has numerous extra-osseous effects, including effects on the cardiovascular system. Indeed, several clinical studies suggest a link between vitamin D deficiency and cardiovascular mortality. The general objective is to evaluate the relationship between vitamin D levels and lipid parameters in patients at Fann University Hospital. Included in this study were 214 patients who came to the laboratory and whose vitamin D dosage was requested between December 2023 and April 2024. Lipid profile parameter dosages were performed with the Architect Ci4100 and vitamin D with Iflash 3000. Correlations between vitamin D levels and blood lipids were assessed by descriptive statistical analysis and Spearman's correlation test. The mean age of our population was 60±17 years and the sex ratio was 0.51. The distribution of patients according to the lipid profile showed that 72.42% of the subjects had a lipid abnormality with a predominance of hypo HDL-cholesterolemia (39.71%). Our study showed a positive and significant correlation between low vitamin D levels and low HDL-cholesterol levels. In contrast, no strong link was found with the levels of total cholesterol, triglycerides and LDL-cholesterol. These results highlight the importance of monitoring vitamin D levels in patients with dyslipidemia, and pave the way for future research on the potential role of vitamin D in cardiovascular risk management. }, year = {2025} }
TY - JOUR T1 - Correlation Between Vitamin D Levels and Dyslipidemia in Patients at Fann University Hospital AU - Kandji Pape Matar AU - Thioune Ndeye Mareme AU - Barry Néné Oumou Kesso AU - Djite Moustapha AU - Nayo Jean Cédric Godwin AU - Ndiaye Siny AU - Coly Najah Fatou AU - Ndour El Malick AU - Gueye-Tall Fatou AU - Gueye Papa Madieye Y1 - 2025/04/19 PY - 2025 N1 - https://doi.org/10.11648/j.ab.20251301.11 DO - 10.11648/j.ab.20251301.11 T2 - Advances in Biochemistry JF - Advances in Biochemistry JO - Advances in Biochemistry SP - 1 EP - 6 PB - Science Publishing Group SN - 2329-0862 UR - https://doi.org/10.11648/j.ab.20251301.11 AB - Vitamin D has been recognized for several decades as an important player in bone metabolism. Beyond these classic effects on mineral metabolism, it has numerous extra-osseous effects, including effects on the cardiovascular system. Indeed, several clinical studies suggest a link between vitamin D deficiency and cardiovascular mortality. The general objective is to evaluate the relationship between vitamin D levels and lipid parameters in patients at Fann University Hospital. Included in this study were 214 patients who came to the laboratory and whose vitamin D dosage was requested between December 2023 and April 2024. Lipid profile parameter dosages were performed with the Architect Ci4100 and vitamin D with Iflash 3000. Correlations between vitamin D levels and blood lipids were assessed by descriptive statistical analysis and Spearman's correlation test. The mean age of our population was 60±17 years and the sex ratio was 0.51. The distribution of patients according to the lipid profile showed that 72.42% of the subjects had a lipid abnormality with a predominance of hypo HDL-cholesterolemia (39.71%). Our study showed a positive and significant correlation between low vitamin D levels and low HDL-cholesterol levels. In contrast, no strong link was found with the levels of total cholesterol, triglycerides and LDL-cholesterol. These results highlight the importance of monitoring vitamin D levels in patients with dyslipidemia, and pave the way for future research on the potential role of vitamin D in cardiovascular risk management. VL - 13 IS - 1 ER -